Is this you? Create Your Porfile
Avatar

Andrew Neil Bowler

Novo Nordisk

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Andrew Neil Bowler is active.

Explore More

Publication

Featured researches published by Andrew Neil Bowler.

Journal of Medicinal Chemistry | 2003

Synthesis and in vitro characterization of 1-(4-aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic acid derivatives. A new class of selective GSK-3 inhibitors.

Preben H. Olesen; Anders R. Sørensen; Birgitte Ursø; Peter Kurtzhals; Andrew Neil Bowler; Ulrich Ehrbar; Bo Falck Hansen

Archive | 2001

2,4-diaminothiazole derivatives and their use as glycogen synthase kinase-3 (gsk-3) inhibitors

Andrew Neil Bowler; Preben H. Olesen; Anders R. Sørensen; Bo Falck Hansen; Helle Worsaae; Peter Kurtzhals

Archive | 2009

Liquid, aqueous, pharmaceutical compositions of factor VII polypeptides

Michael Bech Jensen; Anders Klarskov Petersen; Andrew Neil Bowler

Archive | 2002

Novel 2,4-diaminothiazole derivatives

Andrew Neil Bowler; Bo Falck Hansen

Archive | 2001

Furazanyl-triazole derivates for the treatment of diseases

Preben H. Olesen; Peter Kurtzhals; Helle Worsaae; Bo Falck Hansen; Anders R. Sørensen; Andrew Neil Bowler

Bioorganic & Medicinal Chemistry Letters | 1998

The synthesis of new adenosine A3 selective ligands containing bioisosteric isoxazoles

John Patrick Mogensen; Stanley M. Roberts; Andrew Neil Bowler; Christian Thomsen; Lars Jacob Stray Knutsen

Archive | 2001

Use of 2,4-diaminothiazole derivatives

Andrew Neil Bowler; Preben H. Olesen; Anders R. Sørensen; Bo Falck Hansen; Helle Worsaae; Peter Kurtzhals

Archive | 1997

A method of treating disorders related to cytokines in mammals

Lars Jacob Stray Knutsen; Uffe Bang Olsen; Andrew Neil Bowler

Archive | 1997

Novel n-alkoxyadenine derivatives acting as cytokine inhibitors

Lars Jacob Stray Knutsen; Uffe Bang Olsen; Stanley M. Roberts; David R. Varley; Andrew Neil Bowler

Archive | 2006

Compounds for stabilizing factor vii polypeptide formulations

Anders Klarskov Petersen; Andrew Neil Bowler

Explore More

Collaboration

Dive into the Andrew Neil Bowler's collaboration.

Top Co-Authors
Avatar

Bo Falck Hansen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Anders Klarskov Petersen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Lars Jacob Stray Knutsen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Peter Kurtzhals

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Preben H. Olesen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Uffe Bang Olsen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Anders R. Sørensen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Michael Bech Jensen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Stanley M. Roberts

University of Liverpool

View shared research outputs
Top Co-Authors
Avatar

Birthe Lykkegaard Hansen

Novo Nordisk

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge